Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Gilead hands back one Arcus cancer candidate from $725M deal
The news confirms Gilead's retreat from an asset Arcus deprioritized earlier this year.
Nick Paul Taylor
Aug 7, 2025 6:35am
Kaken strengthens late-stage HAE portfolio with $32M Astria deal
Aug 6, 2025 10:21am
Xoma shops for struggling biotechs, buying HilleVax and Lava
Aug 4, 2025 9:27am
Lepu supplies 2 T-cell engagers to NewCo in $857M deal
Aug 1, 2025 11:11am
Sanofi pens $395M China pact for Arrowhead metabolic med
Aug 1, 2025 7:21am
AbbVie in talks over $1B Gilgamesh buyout: report
Jul 31, 2025 7:48am
